Search

Now showing items 1-1 of 1

Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA.

Lipworth, BJ; Collier, DJ; Gon, Y; Zhong, N; Nishi, K; Chen, R; Arora, S; Maes, A; Siddiqui, S; Reisner, C;... (Dove Medical Press Limited., 2018)

Background: COPD is a major global cause of mortality and morbidity. PINNACLE-4 evaluated the efficacy and safety of GFF MDI (glycopyrrolate/formoterol fumarate metered dose inhaler) in patients from Asia, Europe, and the ...